Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; …
Last updated
21 Aug 2026
Exchange
NSE India · NSI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
INR
Market capitalisation
76,279,859,803
Fair value reference
656.69
Next-week expectancy
Undecided · 45.56%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-21, AARTIPHARM rose 30.03%, moving from 628.30 to 817.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 1 of the last 12 weeks. Relative Strength is 12.45 and has improved across the 12-week window. Market Dynamics is 0.70 on the latest week. Next-week expectancy is undecided at 45.56% based on similar historical setup states.
Week Ending
21 Aug 2026
Latest Close
817.00
12-Week Change
30.03%
Trend Signal
Active
Next-Week Expectancy
Undecided 45.56%
Signal Weeks
1 of 12
+
Blank comparison canvas
Add the charts you want to study together
Use the chart library to assemble a view. You can reorder charts, change the number shown per row, or expand any chart for its complete analysis.
Weekly Trend
Weekly Close
Trend Line
Fair Value
Activity Lines
Analysis panels
Choose up to 6 panels. Drag panel headers to reorder.
Price Action
Completed weekly market tape
Price Action
A deep view of how price is behaving against its own completed history, trend, structural levels and participation.
Current weekly interpretationAdvancing structure with weak close
Recent completed price swings are progressing higher on both sides of the range. Price is above its completed-week trend reference, while the reference is falling.
Full context · Unstable
Current structureAdvancing structure
Recent completed price swings are progressing higher on both sides of the range.
Trend relationshipAbove trend
Price is above its completed-week trend reference, while the reference is falling.
Support and resistanceSupport 717.83 · Resistance 932.60
Nearest completed structural references around the latest close.
The negative weekly move attracted clearly elevated participation.
Price, structure and participation
Where price advanced, failed, reclaimed or lost important ground
Candles preserve the completed weekly tape. Selected annotations identify meaningful finished events and point directly to the week concerned.
Up weekDown weekTrend referenceCompleted supportCompleted resistanceVolumeTypical volumePublished event
What happened this week?
The latest completed candle
The latest week is separated into price change, candle character, closing position and path quality.
Weekly move-4.02%
Latest close versus the preceding completed close.
Candle characterWeak close
Price declined and finished in the lower part of the completed weekly range.
Where the week closedNear the weekly low
The close finished at 12% of the completed weekly range.
Path qualityUnstable
Frequent recent changes in direction reduce confidence in the current price path.
Current evaluation
What the weekly tape says now
The interpretation combines completed price structure, trend relationship, participation and path quality.
What supports it
Recent completed price swings are progressing higher on both sides of the range.
What would improve it
A sustained close above the nearest completed resistance, supported by firmer participation, would improve confirmation.
What could weaken it
A sustained loss of the nearest completed support would materially weaken the current price structure.
What to watch next
Trend relationship is above trend; participation is strong negative participation, and path quality is unstable.
Statistical perspective
Where the latest close sits in its own completed history
These observations describe the available record. They are market context, not predictions of the next move.
Position in completed history81% of range
The latest close's location between the lowest and highest completed closes available for this market.
Distance from completed high-13.7%
How far the latest close sits below the highest completed close in the available history.
Recovery from completed low+219.2%
How far the latest close has advanced from the lowest completed close in the available history.
Latest move versus typical1.3× typical
The absolute latest weekly move compared with completed weekly moves available before it.
Completed event history
What changed, and when
Only selected completed events are shown. Each annotation is descriptive, not a standalone instruction.
Trend reclaimed
The weekly close moved back above the completed trend reference.
1 week ago
Trend lost
The weekly close moved below the completed trend reference.
14 weeks ago
Support structure lost
The weekly close moved below the preceding completed price structure.
21 weeks ago
High-participation reversal
Price changed weekly direction with elevated participation.
27 weeks ago
Upside structure cleared
The weekly close moved above the preceding completed price structure.
31 weeks ago
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateAbove the trend range
52-week position
64.6%
Low to high
Accepted price
754.21
Latest versus accepted: 8.33%
Fitted direction
Falling
-0.50% per week
Range pressure
77/100
Upper pressure
Range condition
Expanding
1.29× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support721.62
From price
-11.7%
Evidence
94/100
Touches
5
Support754.21
From price
-7.7%
Evidence
100/100
Touches
4
Support782.59
From price
-4.2%
Evidence
43/100
Touches
1
Current pivot815.09
From price
-0.2%
Evidence
72/100
Touches
4
Resistance834.62
From price
2.2%
Evidence
40/100
Touches
1
Resistance880.28
From price
7.7%
Evidence
66/100
Touches
2
Current reading
What the range shows
Current positionAbove the trend range
Price is at 64.6% of its latest 52-week range.
Fitted directionFalling
The fitted centre line is moving -0.49% per week.
Range pressureUpper pressure
The current pressure reading is 77/100; 50 is balanced.
Next structural level834.62
Resistance is 2.2% from the latest close with 40/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Completed-week positioning evidence
Smart Money
See whether the support beneath price is strengthening, weakening, confirming the trend or warning of increased risk.
Current Smart Money readUnderlying support is constructive and strengthening
The visible Smart Money evidence is aligned and its completed-week momentum path is improving.
Momentum 0.44 · Improving
Trend qualityStrong alignment
The current trend state has persisted for 1 completed week; visible confirmation is strong alignment.
Momentum pathBalanced · Improving
The latest completed-week level and direction.
Latest positive signalNo recent positive signal
The chart is carrying context rather than a fresh positive event marker.
Risk and warningsNormal
Earlier warnings are outside the recent completed-week window.
Price, support and published events
Where confirmation strengthened or risk increased
Selected annotations highlight meaningful completed-week events; every existing chart series and marker remains visible.
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Current evaluation
What the Smart Money chart means now
The reading combines the finished chart state, its direction and the timing of published signals.
What supports it
The current trend relationship and completed-week context are broadly aligned.
What would improve it
Continued alignment without a new warning would reinforce the current constructive position.
What could weaken it
There is no fresh positive event marker, so the current reading depends on continued confirmation rather than a new signal.
Published signal history
What changed, and when
Event markers are observations, not standalone instructions to buy or sell.
Reversal danger
The chart registered its strongest reversal warning.
48 weeks ago
Reversal risk
The chart registered elevated reversal risk.
49 weeks ago
Reversal danger
The chart registered its strongest reversal warning.
62 weeks ago
Reversal risk
The chart registered elevated reversal risk.
64 weeks ago
Market Dynamics
Price and underlying support
Market Dynamics
See whether the support beneath price is strengthening, weakening, confirming the move or beginning to diverge from it.
A completed close above 13-week VWAP with pressure holding above 60 would strengthen buyer control.
Decision area817.29
13-week VWAP at 817.29, 0.0% above the latest close.
Weakening level787.95
A completed close below 52-week VWAP with acceptance moving under 50% would weaken the present structure.
Current VWAP stack
Volume-weighted price levels
13-week VWAP817.29
+0.03% from close
Swing low839.54
+2.76% from close
52-week VWAP787.95
-3.56% from close
High-activity anchor848.10
+3.81% from close
26-week VWAP782.74
-4.19% from close
Year VWAP777.89
-4.79% from close
Estimated activity position
Activity above and below price
Below price 48%Above price 52%
43%near price
A notable share of recent weighted activity remains above price and may act as overhead supply.
Estimated from completed weekly typical prices and reported activity; it is not holder-level cost-basis data.
Benchmark, sector and industry
VWAP control comparison
Sector and industry comparisons require at least ten constituents with aligned completed history.
Benchmark · ^NSEIStronger control than reference
Stronger control than reference; control-score gap +29.8 points.
Control is contested · 48/100
Sector · HealthcareWeaker control than reference
Weaker control than reference; control-score gap -10.6 points.
Buyers firmly in control · 89/100
Industry · Drug Manufacturers - Specialty & GenericWeaker control than reference
Weaker control than reference; control-score gap -11.4 points.
Buyers firmly in control · 90/100
Historical VWAP outcomes
Reclaims, losses and similar states
Descriptive outcomes from this ticker's visible history—not a forecast.
Weekly reclaim50% favourable
Events
8
Median 4w
-0.62%
Median 13w
-2.67%
Typical best
+6.74%
Typical worst
-12.42%
Completed occasions when price moved back above the core VWAP.
Weekly loss33% favourable
Events
9
Median 4w
+6.87%
Median 13w
+16.06%
Typical best
+20.99%
Typical worst
-5.69%
Completed occasions when price moved below the core VWAP.
Comparable control states57 matched weeks
Positive after 4w
47%
Median 4w
-0.97%
Positive after 13w
63%
Median 13w
+4.60%
Best / worst 13w
+29.7% / -19.9%
Outcomes after completed weeks with a similar control score and the same side of the core VWAP.
VWAP control history
Completed changes
Core VWAP reclaimed
Price completed the week back above the core VWAP.
VWAP structure turned lower
The fast VWAP crossed below the core VWAP.
Core VWAP lost
Price completed the week below the core VWAP.
Core VWAP test held
Price traded through the core VWAP but recovered above it by the completed close.
Core VWAP reclaimed
Price completed the week back above the core VWAP.
VWAP reclaim rejected
Price tested above the core VWAP but completed the week back below it.
VWAP reclaim rejected
Price tested above the core VWAP but completed the week back below it.
VWAP reclaim rejected
Price tested above the core VWAP but completed the week back below it.
SMI
Proprietary completed-week evidence
SMI
See whether the underlying conditions beneath price are strengthening, weakening or holding firm.
Current SMI readUnderlying support remains weak, with an early improvement
Price and SMI are not presenting a decisive combined message. The latest reading is based on completed weekly evidence.
0.18 · Weak
Current stateWeak · 0.18
Latest completed-week SMI reading
DirectionImproving
How the completed SMI path is changing
PersistenceEstablished
34 completed weeks in the current state
Price relationshipMixed relationship
Price and SMI are not presenting a decisive combined message.
Price and SMI transitions
Where underlying support changed
Annotations identify selected completed SMI state changes.
Weekly CloseTrend LineFair ValueActivity Lines
SMI pathDirection, persistence and turning points
SMI 0.18 · Weak
ImprovingHolding steadyWeakening
SMI in context
Comparable SMI states have carried a cautious historical bias
Across 8 comparable completed observations, 37.5% closed higher after 13 weeks. The median move was -7.4%.
Comparable observations
8
Completed historical readings
Positive outcomes
37.5%
After 13 completed weeks
Median move
-7.4%
Over the following 13 weeks
Versus normal baseline
-24.6 pts
Difference in positive outcome rate
Chart Summary
Key Points
Week Ending
21 Aug 2026
Latest Close
817.00
12-Week Change
30.03%
Trend Signal
Active
Next-Week Expectancy
Undecided 45.56%
Signal Weeks
1 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
12.45
Market Dynamics
0.70
Over the latest 12 completed weeks ending 2026-08-21, AARTIPHARM rose 30.03%, moving from 628.30 to 817.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 1 of the last 12 weeks. Relative Strength is 12.45 and has improved across the 12-week window. Market Dynamics is 0.70 on the latest week. Next-week expectancy is undecided at 45.56% based on similar historical setup states.
Industry Peers
India equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Markets includedUnited States
Start typing to find a stock or ETF.
Market search
Choose countries
Choose one or more countries for market search, or include every covered market.
Currently searching United States
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
